In preclinical animal trials, third-party testing results showed that AIM Vaccine’s mRNA RSV vaccine achieved significantly higher levels of specific IgG antibody titers, live-virus neutralizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback